Key result
Higher RAVI/LAVI ratio linked to ~71% higher risk of death or LVAD in cardiogenic shock.
Why the study?
Determinants of outcomes among patients with cardiogenic shock in the setting of chronic systolic heart failure are poorly understood, and novel echocardiographic markers of atrial remodeling may improve risk stratification.
Does an increased RAVI/LAVI ratio increase the risk of death or LVAD implantation in patients with HFrEF and cardiogenic shock?
Cohort (n=113)
No
Does an increased RAVI/LAVI ratio increase the risk of death or LVAD implantation in patients with HFrEF and cardiogenic shock?
Hazard Ratio: 1.71 (95% CI 1.11–2.64)
p-value: p=0.010
An elevated RAVI/LAVI ratio provides a readily available, non-invasive echocardiographic parameter for risk stratifying patients with HFrEF presenting with cardiogenic shock.
May support risk stratification with RAVI/LAVI in cardiogenic shock; hypothesis-generating and requires prospective validation.
BACKGROUND: Structural remodeling in chronic systolic heart failure (HF) is associated with neurohormonal and hemodynamic perturbations among HF patients presenting with cardiogenic shock (CS) and HF. Our objective was to test the hypothesis was that atrial remodeling marked by an increased right atrial volume index (RAVI) to left atrial volume index (LAVI) ratio is associated with adverse clinical outcomes in CS. METHODS: Patients in this cohort were admitted to the intensive care unit with evidence of congestion (pulmonary capillary wedge pressure > 15) and cardiogenic shock (cardiac index < 2.2, systolic blood pressure < 90 mmHg, and clinical evidence supporting CS) and had an echocardiogram at the time of admission. RAVI was measured using Simpson's method in the apical four-chamber view, while LAVI was measured using the biplane disc summation method in the four and two-chamber views by two independent observers. Cox proportional hazards regression analysis was used to assess the association of RAVI-LAVI with the combined outcome of death or left ventricular assist device (LVAD). RESULTS: Among 113 patients (mean age 59 ± 14.9 years, 29.2% female), median RAVI/LAVI was 0.84. During a median follow-up of 12 months, 43 patients died, and 65 patients had the combined outcomes of death or LVAD. Patients with RAVI/LAVI ratio above the median had a greater incidence of death or LVAD (Log-rank p ≤ 0.001), and increasing RAVI/LAVI was significantly associated with the outcomes of death or LVAD (HR 1.71 95% CI 1.11-2.64, chi square 5.91, p = 0.010) even after adjustment for patient characteristics, echocardiographic and hemodynamic variables. CONCLUSION: RAVI/LAVI is an easily assessed novel echocardiographic parameter strongly associated with the survival and or the need for mechanical circulatory support in patients with CS.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2021) conducted a cohort in Cardiogenic shock and HFrEF (n=113). Increased right atrial volume index to left atrial volume index (RAVI/LAVI) ratio vs. Lower RAVI/LAVI ratio was evaluated on Composite of death or left ventricular assist device (LVAD) implantation (HR 1.71, 95% CI 1.11-2.64, p=0.010). An increasing RAVI/LAVI ratio was significantly associated with a higher risk of death or LVAD implantation (HR 1.71) in patients with cardiogenic shock.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: